Baptist Cancer Program - Baptist Memorial Health Care

Brain Tumors: A Look at Tumor Registry Data—con’t
Lastly, we took a look at observed survival. As can be seen in the table depicted below, survival in the first
three years is far lower than reported nationally. However, 5-year survival is quite similar.
Comparison of 5-Year Observed Survival of Primary Brain Tumors (NCDB)
Baptist
2005-2006
National
2003-2004
Observed Survival
ENTER 0 yr 1.0 yr 2.0 yr 3.0 yr 4.0 yr 5.0 yr
65 100% 38.1% 25.4% 25.4% 22.6% 22.6%
21054 100% 52.5% 34.5% 28.3% 25.3% 23.0%
Conclusion:
The number of brain cases seen at Baptist decreased between 2005 and 2008. The reason for this
decrease is unknown. Brain tumors appear to be more prevalent in males than females. Incidence
increases with age, peaking at age 79. The incidence of brain tumors in whites far exceeds that of any
other race or ethnicity group. The vast majority of brain tumors seen are malignant. The vast majority of
brain tumors diagnosed are glioblastomas. Surgery alone is the predominant intervention for primary
brain tumors. The greatest proportion of brain tumors are treated in 2 days or less. Five-year observed
survival is approximately 23%.
Tumor Registry data collection of chemotherapy data, especially in the physician office is questionable.
Tumor Registry data collection of brain and other central nervous system tumors is based solely on
primary tumors and excludes metastatic tumors.
More in depth data collection of both primary and metastatic central nervous system tumor is needed. The
feasibility of a possible central nervous system registry should be explored for more meaningful collection
of data.
Page33